Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 51 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DiabHealth from Perwez, company number BE0793274215, closed financial year 2025 with a result of € -3,366 after tax. For that financial year DiabHealth recorded a gross margin of € -2,875 and equity of € -2,808. Compared with financial year 2024, the result moved from € -1,629 to € -3,366. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ -2,808
▼ € 3,367 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3,366
▼ 107 % more loss than in 2024
Profit after tax over the fiscal year.
€ 659
▼ 62% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -10,808.
Debts at end 2025
€ 32
Loans from banks and other lenders, long and short.
€ 327
▼ 83% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -5,056 | € -1,154 | € -2,875 | ▼ € 1,720 |
| Profit after taxes | € -5,812 | € -1,629 | € -3,366 | ▼ € 1,737 |
| Equity | € 2,188 | € 559 | € -2,808 | ▼ € 3,367 |
| Total debts | € 769 | € 2,528 | € 6,398 | ▲ 153% |
| Cash | € 2,069 | € 1,713 | € 659 | ▼ 62% |
| Retained profit | € -5,812 | € -7,441 | € -10,808 | ▼ € 3,367 |
| Bank debt | € 0 | € 0 | € 32 | |
| Balance sheet total | € 2,957 | € 3,087 | € 3,590 | ▲ 16% |
Key figures of DiabHealth, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DiabHealth?
What happened at DiabHealth in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 3,367. Source: NBB ↗
- New establishment in Perwez. KBO
- François Temmerman became a director. NBB
- Thibaut Hermant became a director. NBB
- Nicolas Descamps became a director. NBB
- Gauthier Bohyn became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 5,812 loss in 2023 to € 3,367 loss in 2025.
A new publication or filing at DiabHealth? We notify you, reason included.
Follow DiabHealthDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DiabHealth are François Temmerman, Thibaut Hermant, Nicolas Descamps and Gauthier Bohyn.
Directors
According to the 2025 annual accounts
François Temmerman
Director
since 2022
Thibaut Hermant
Director
since 2022
Nicolas Descamps
Director
since 2022
Gauthier Bohyn
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Rue Sainte Wivine 1
1360 Perwez
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0793.274.215
- VAT number
- BE 0793.274.215
- Registered office
- Rue Sainte Wivine 1, 1360 Perwez
- Names & denominations
- DiabHealth
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 November 2022
- Peppol
- Active · Active since 9 Nov 2022
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Activiteiten op het gebied van voeding
Activiteiten van webportalen
Overige vormen van onderwijs
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computerconsultancy-activiteiten
Webportalen
+1